0001827090-25-000048
SEC filingRevenue grew 10% in Q3 2025, driven by acquisitions and organic growth, with net income turning positive to $1.5M.
For the three months ended September 30, 2025, total revenue increased 10% to $104.6 million compared to $94.8 million in the prior year quarter. The growth was driven by the Chemaxon acquisition ($5.8M contribution) and organic expansion across software and services. Software revenue rose 22% to $43.8 million, while services revenue grew 3% to $60.8 million. Cost of revenues increased 7% to $39.7 million, resulting in gross margin improvement to 62.0% from 60.8% due to revenue mix. Operating expenses (S&M, R&D, G&A, D&A) totaled $61.9 million, up 11% from $55.0 million, with notable increases in R&D (24% to $10.3M) as the company invests in AI integration. Net income turned positive to $1.5 million from a net loss of $1.4 million, driven by revenue growth and higher other income. For the nine-month period, revenue increased 11% to $315.2 million, net income improved to $4.3 million from a loss of $18.6 million, and operating cash flow more than doubled to $67.5 million.
Software segment revenue grew 21% year-to-date to $136.9 million, with the Chemaxon acquisition contributing $16.2 million; organic software growth remained solid as net retention rates averaged 104.6% through Q3 2025. Services revenue increased 4% to $178.3 million, driven by continued demand for technology-enabled services. The revenue mix continued to shift toward software, which now represents 43% of total revenue versus 40% in the prior year period.
Management does not provide specific quantitative guidance in this MD&A. However, they emphasize continued investment in growth areas including AI integration across software, expansion of the commercial organization, and strategic acquisitions. The company remains focused on customer retention and expansion, with new bookings of $96.6 million in Q3 2025. The recent U.S. government shutdown and potential regulatory changes are noted as uncertainties but have not materially impacted operations to date. The company expects to maintain positive cash flow and has ample liquidity through its $172.7 million cash balance and $100 million revolver.
As of September 30, 2025, Certara held $172.7 million in cash and cash equivalents, down from $179.2 million at year-end 2024. Total debt (current and long-term) stood at $293.5 million, a slight decrease of $1.9 million from $295.4 million. The debt consists of a term loan with $296.3 million principal, partially offset by $2.7 million in unamortized debt issuance costs. The company also has an undrawn $100 million revolving credit facility. Stockholders' equity increased to $1.065 billion from $1.059 billion, driven by net income and equity issuances partially offset by share repurchases.
Operating lease commitments total $16.2 million, with maturities ranging from less than one to nine years. The weighted-average remaining lease term is 5.8 years. Additionally, contingent consideration liabilities related to acquisitions amount to $22.4 million (current) and $0 (long-term), with $18.9 million paid in cash and stock during the nine-month period. No other material purchase commitments are disclosed.
In April 2025, the Board authorized a $100 million share repurchase program. During the nine months ended September 30, 2025, the company repurchased 3.0 million shares for $38.7 million, leaving $61.3 million remaining. No dividends were paid. Capital expenditures totaled $19.5 million, including $18.8 million in capitalized software development costs, representing 6.2% of revenue. Debt repayments were $2.3 million, with no new borrowings in 2025.
Certara operates as a single segment. Geographic revenue breakdown for the nine months: Americas $218.9M (69.5%), EMEA $71.1M (22.6%), Asia Pacific $25.2M (8.0%). The mix reflects a stable contribution from Americas compared to prior year.
Overall, the notes reveal a supportive liquidity position, active capital return via buybacks, and modest capital expenditure relative to revenue.
Net cash from operations (CFO) of $67.5M for the nine months ended September 30, 2025, reflects a significant improvement from $31.1M in the prior-year period, driven by a swing to net income of $4.3M from a net loss of $18.6M. Non-cash adjustments (depreciation & amortization: $56.1M, stock compensation: $24.9M) and a $13.4M decrease in accounts receivable contributed positively, while deferred revenue declined $15.6M, a headwind.
Capital expenditures totaled $19.5M, comprising $0.8M in traditional capex and $18.8M in capitalized software development, representing 29% of CFO. No free cash flow figure is provided; however, CFO less capex implies $48.0M. Share repurchases of $38.7M consumed a substantial portion of operational cash flow.
Financing activities also included $2.3M in debt repayments and $13.2M in contingent consideration payments. Interest paid of $10.5M and taxes paid of $8.8M were disclosed. Overall, strong cash generation from operations, supported by working capital management and higher earnings, enabled notable capital returns.